Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. Huckel and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
182
Frequently Asked Questions
What is Market Cap of Catalyst Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Catalyst Pharmaceuticals Inc market cap is $3.84B.
What is the 52-week high for Catalyst Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Catalyst Pharmaceuticals Inc 52 week high is $32.56 as of June 24, 2026.
What is the 52-week low for Catalyst Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Catalyst Pharmaceuticals Inc 52 week low is $19.05 as of June 24, 2026.
What is Catalyst Pharmaceuticals Inc stock price today?
Catalyst Pharmaceuticals Inc stock price today is $31.40.
What was Catalyst Pharmaceuticals Inc stock price yesterday?
Catalyst Pharmaceuticals Inc stock price yesterday was $31.38.
What is the PE ratio of Catalyst Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Catalyst Pharmaceuticals Inc's P/E ratio is 18.05.
What is the Price-to-Book ratio of Catalyst Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Catalyst Pharmaceuticals Inc P/B ratio is 3.7884.
What is the 50-day moving average of Catalyst Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Catalyst Pharmaceuticals Inc 50-day moving average is $29.94.
How many employees does Catalyst Pharmaceuticals Inc have?
